Skip to main content
Conference ProceedingsOPEN ACCESS

Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents

Clinical Infectious Diseases (2016) 63(5) 651-653
DOI: 10.1093/cid/ciw401
75Citations
Citations of this article
107Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We compared rates of recurrent Clostridium difficile infection in patients receiving or not receiving oral vancomycin prophylaxis with systemic antimicrobial therapy. The incidence of C. difficile infection was significantly lower in patients receiving prophylaxis (4.2% vs 26.6% in those without prophylaxis; odds ratio, 0.12; 95% confidence interval,. 04-.4; P <. 001).

Author supplied keywords

Cite

CITATION STYLE

APA

Van Hise, N. W., Bryant, A. M., Hennessey, E. K., Crannage, A. J., Khoury, J. A., & Manian, F. A. (2016). Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents. In Clinical Infectious Diseases (Vol. 63, pp. 651–653). Oxford University Press. https://doi.org/10.1093/cid/ciw401

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free